Home » Marijuana & CBD

Marijuana & CBD

Featured posts

How to provide comment for the DEA’s Notice of Proposed Rulemaking (NPRM) regarding the rescheduling of marijuana 

Make your voice heard! You can have an impact on the U.S. Drug Enforcement Administration’s proposal to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act by providing comment to the NPRM. The deadline for submitting...

Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests

Reprinted article courtesy of Quest Diagnostics, a leading provider of diagnostic information services. Key Findings The overall drug positivity held steady at historically high rates in 2023, while marijuana positivity continued an upward climb in the general U.S....

National Drug & Alcohol Screening Association Urges Protection of Transportation Safety Amid Marijuana Rescheduling Debate

Rescheduling marijuana to Schedule III will prevent the U.S. Department of Transportation from prohibiting active use for those in transportation safety positions. Without a safety carveout - or a clear plan to prevent this unintended consequence, the traveling public...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts